PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: EAP treatment completed and Orphan Status achieved for MPS-I, page-26

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    Full results are not being published till Q3. There was an indication that they were going to release an update on the first 5 shortly.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.